GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BenQ Medical Technology 4116.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

40.40

+0.12%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 5.25bn

FY2016FY2025

Net income

TWD 78.2m

FY2016FY2025

Free cash flow

TWD 259.5m

FY2016FY2025

Shareholders' equity

TWD 1.13bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 5.25bnTWD 4.77bnTWD 4.54bnTWD 2.95bnTWD 1.46bnTWD 1.40bnTWD 1.38bnTWD 1.23bnTWD 1.04bnTWD 876.0m
Gross profitTWD 1.69bnTWD 1.45bnTWD 1.34bnTWD 860.2mTWD 512.3mTWD 551.6mTWD 547.9mTWD 466.0mTWD 423.6mTWD 307.5m
Research and developmentTWD 34.7mTWD 36.4mTWD 32.0mTWD 39.6mTWD 39.6mTWD 44.3mTWD 44.8mTWD 38.4mTWD 46.4mTWD 55.4m
Operating incomeTWD 346.0mTWD 333.4m—TWD 286.6mTWD 67.5mTWD 109.8mTWD 123.5mTWD 93.6mTWD 69.2mTWD 53.6m
Net incomeTWD 78.2mTWD 104.8mTWD 114.6mTWD 180.2mTWD 28.8mTWD 62.1mTWD 75.4mTWD 66.7mTWD 46.6mTWD 46.3m
Diluted earnings per share1.742.332.564.020.651.391.681.481.041.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 5.45bnTWD 5.27bnTWD 4.71bnTWD 3.40bnTWD 1.96bnTWD 1.79bnTWD 1.69bnTWD 1.68bnTWD 1.54bnTWD 1.37bn
Cash and short-term investments———TWD 839.5mTWD 421.3mTWD 343.5mTWD 295.9m——TWD 290.3m
Total liabilitiesTWD 3.12bnTWD 2.97bnTWD 2.53bnTWD 1.66bnTWD 855.5mTWD 677.8mTWD 585.3mTWD 589.3mTWD 475.8mTWD 375.0m
DebtTWD 534.4mTWD 868.9mTWD 843.1mTWD 852.1mTWD 491.7mTWD 303.3mTWD 240.7mTWD 200.0mTWD 60.0mTWD 86.9m
Shareholders' equityTWD 1.13bnTWD 1.12bnTWD 1.10bnTWD 1.20bnTWD 1.04bnTWD 1.05bnTWD 1.05bnTWD 1.04bnTWD 1.02bnTWD 997.4m
Shares outstanding45m45m45m45m45m45m45m45m45m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 358.8mTWD 222.2mTWD 442.3mTWD 378.8mTWD 121.3mTWD 151.5mTWD 169.2mTWD 126.1mTWD 73.0mTWD 71.4m
Capital spending−TWD 99.2m−TWD 175.5m−TWD 139.3m−TWD 60.1m−TWD 32.9m−TWD 42.4m−TWD 21.1m−TWD 31.4m−TWD 112.3m−TWD 161.5m
Free cash flowTWD 259.5mTWD 46.7mTWD 303.1mTWD 318.7mTWD 88.4mTWD 109.1mTWD 148.1mTWD 94.7m−TWD 39.3m−TWD 90.2m
Dividends paid−TWD 73.5m−TWD 89.1m−TWD 93.6m−TWD 22.3m−TWD 44.6m−TWD 60.2m−TWD 60.2m−TWD 44.6m−TWD 31.0m−TWD 66.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.43bnTWD 1.32bnTWD 1.37bnTWD 1.32bnTWD 1.33bnTWD 1.23bnTWD 1.32bnTWD 1.21bn
Gross profitTWD 461.5mTWD 427.2mTWD 451.8mTWD 427.6mTWD 414.0mTWD 396.2mTWD 406.7mTWD 370.7m
Operating incomeTWD 90.6m——TWD 81.2mTWD 88.4mTWD 73.5mTWD 103.8m—
Net incomeTWD 59.0mTWD 12.6mTWD 18.7mTWD 27.5mTWD 9.8mTWD 22.3mTWD 26.3mTWD 26.6m
Diluted earnings per share1.310.280.420.610.220.500.590.59
Cash from operationsTWD 148.0mTWD 29.0mTWD 106.0m—TWD 179.0m−TWD 45.0mTWD 86.0mTWD 82.0m
Capital spending−TWD 9.0m−TWD 15.0m−TWD 33.0m—−TWD 14.0m−TWD 41.0m−TWD 46.0m−TWD 28.0m
Free cash flowTWD 139.0mTWD 14.0mTWD 73.0m—TWD 165.0m−TWD 86.0mTWD 40.0mTWD 54.0m
Total assetsTWD 5.52bnTWD 5.58bnTWD 5.45bnTWD 5.24bnTWD 5.27bnTWD 5.30bnTWD 5.27bnTWD 4.96bn
Cash and short-term investments———TWD 1.09bn————
DebtTWD 627.8mTWD 758.4mTWD 534.4mTWD 1.79bnTWD 848.9mTWD 825.1mTWD 868.9mTWD 824.5m
Shareholders' equityTWD 1.10bnTWD 1.05bnTWD 1.13bnTWD 1.09bnTWD 1.06bnTWD 1.07bnTWD 1.12bnTWD 1.10bn

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin32.2%30.4%29.6%29.1%35.0%39.4%
Operating margin7.2%7.6%8.8%9.7%4.6%7.8%
Net margin1.5%2.2%2.5%6.1%2.0%4.4%
Return on equity6.9%9.3%10.4%15.0%2.8%5.9%
Return on assets1.4%2.0%2.4%5.3%1.5%3.5%
Free cash flow yield—11.2%22.4%19.1%6.2%7.7%
Revenue growth10.2%4.9%53.9%101.5%4.6%1.5%
Earnings growth-25.4%-8.5%-36.4%525.0%-53.5%-17.7%
Current ratio1.62x1.75x1.99x1.72x1.88x1.66x
Debt to equity0.47x0.77x0.77x0.52x0.43x0.24x
Equity ratio20.7%21.3%23.3%35.3%53.1%58.7%
Interest coverage8.50x10.62x14.35x21.22x17.25x27.34x
R&D as a share of sales0.7%0.8%0.7%1.3%2.7%3.2%
Buybacks as a share of market value—-0.5%0.2%-0.6%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.2%30.3%18.8%
Operating income6.5%25.8%53.5%
Net income-24.3%4.7%-4.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin31.3%30.5%31.4%32.7%
Operating margin6.8%———
Net margin1.8%2.7%2.8%3.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings25.420.225.015.951.326.222.218.835.136.6
Price to sales0.40.40.61.01.01.21.21.01.61.9

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 30 Jun 2025.

FY2025FY2024FY2023FY2022
Paid in the year1.652.002.100.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.